Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

1.14.18.1: tyrosinase

This is an abbreviated version!
For detailed information about tyrosinase, go to the full flat file.

Word Map on EC 1.14.18.1

Reaction

2 L-dopa +

O2
= 2 dopaquinone + 2 H2O

Synonyms

AbPPO1, AbPPO4, AbTYR, aurone synthase, catalase-phenol oxidase, catechol oxidase, catecholase, CATPO, chlorogenic acid oxidase, chlorogenic oxidase, cresolase, cresolase/monophenolase, CsPPO, CZA14Tyr, deoxy-tyrosinase, dihydroxy-L-phenylalanine:oxygen oxidoreductase, Diphenol oxidase, diphenolase, dopa oxidase, EC 1.10.3.1, EC 1.14.17.2, Hc-derived phenoloxidase, Hc-phenoloxidase, HcPO, HdPO, hemocyanin-derived phenoloxidase, jrPPO1, jrTYR, L-DOPA monophenolase, L-DOPA oxidase, L-DOPA:oxygen oxidoreductase, L-tyrosine hydroxylase, MdPPO1, melC2, MelC2 tyrosinase, met-tyrosinase, monophenol dihydroxyphenylalanine:oxygen oxidoreductase, monophenol monooxidase, monophenol monooxygenase, monophenol monoxygenase, monophenol oxidase, monophenol oxygen oxidoreductase, monophenol, 3,4-dihydroxy L-phenylalanine (L-DOPA):oxygen oxidoreductase, monophenol, dihydroxy-L-phenylalanine oxygen oxidoreductase, monophenol, dihydroxy-L-phenylalanine:oxygen oxidoreductase, monophenol, dihydroxyphenylalanine:oxygen oxidoreductase, monophenol, L-Dopa: oxidoreductase, monophenol, L-DOPA: oxygen oxidoreductase, monophenol, o-diphenol: oxygen oxidoreductase, monophenol, o-diphenol:O2 oxidoreductase, monophenol, o-diphenol:oxygen oxido-reductase, monophenol, o-diphenol:oxygen oxidoreductase, monophenol, polyphenol oxidase, monophenol: dioxygen oxidoreductases, hydroxylating, monophenolase, monphenol mono-oxygenase, More, mTyr, murine tyrosinase, mushroom tyrosinase, mushroom tyrosine, N-acetyl-6-hydroxytryptophan oxidase, o-diphenol oxidase, o-diphenol oxidoreductase, o-diphenol oxygen oxidoreductase, o-diphenol: O2 oxidoreductase, o-diphenol: oxidoreductase, o-diphenol:O2 oxidoreductase, o-diphenol:oxygen oxidoreductase, o-diphenolase, OCA1, Orf13, oxygen oxidoreductase, phenol oxidase, phenol oxidases, phenolase, phenoloxidase, PO, polyaromatic oxidase, polyphenol oxidase, polyphenol oxidase 3, polyphenol oxidase 4, polyphenol oxidase B, polyphenolase, polyphenoloxidase, PotPPO, PPO, PPO 3, PPO B, PPO1, PPO2, PPO3, pro-PO III, prophenoloxidase III, pyrocatechol oxidase, SPRTyr, ST94, ST94t, tryosinase, tryrosinase, TY, tyr, TYR1, TYR2, tyrA, TyrBm, tyrosinase, tyrosinase 2, tyrosinase 4, tyrosinase diphenolase, tyrosine-dopa oxidase

ECTree

     1 Oxidoreductases
         1.14 Acting on paired donors, with incorporation or reduction of molecular oxygen
             1.14.18 With another compound as one donor, and incorporation of one atom of oxygen into the other donor
                1.14.18.1 tyrosinase

Inhibitors

Inhibitors on EC 1.14.18.1 - tyrosinase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(+)-gallocatechin-3-O-gallate
(+)haemanthamine
-
-
(-)-epicatechin-3-O-gallate
(-)-epigallocatechin
(-)-epigallocatechin-3-O-gallate
(1E,2E)-3-(2,4-dimethoxyphenyl)-N-hydroxy-1-(pyridin-2-yl)prop-2-en-1-imine
-
52.5% inhibition at 50 mM
(1E,4E)-1,5-bis(2-fluoro-4-methoxyphenyl)penta-1,4-dien-3-one
-
-
(1E,4E)-1,5-bis(4-fluorophenyl)penta-1,4-dien-3-one
-
-
(1E,4E)-1,5-bis(4-hydroxy-3-methoxyphenyl)penta-1,4-dien-3-one
-
-
(2-([4-(4-methoxy-benzyloxy)-benzylidene]-hydrazono)-4-oxothiazolidin-5-ylidene)-acetic acid methyl ester
-
-
(2-[(2-hydroxy-benzylidene)-hydrazono]-4-oxo-thiazolidin-5-ylidene)-acetic acid methyl ester
-
-
(2-[(5-methyl-furan-2-ylmethylene)-hydrazono]-4-oxothiazolidin-5-ylidene)-acetic acid methyl ester
-
-
(2E)-1-(2-hydroxyphenyl)-3-(pyridin-2-yl)prop-2-en-1-one
-
59.2% inhibition at 50 mM
(2E)-1-(2-hydroxyphenyl)-3-(pyridin-3-yl)prop-2-en-1-one
-
55.9% inhibition at 50 mM
(2E)-1-(2-hydroxyphenyl)-3-(pyridin-4-yl)prop-2-en-1-one
-
48.9% inhibition at 50 mM
(2E)-1-(3-hydroxynaphthalen-2-yl)-3-(pyridin-2-yl)prop-2-en-1-one
-
49.5% inhibition at 50 mM
-
(2E)-1-(3-hydroxynaphthalen-2-yl)-3-(pyridin-3-yl)prop-2-en-1-one
-
59.2% inhibition at 50 mM
(2E)-1-(3-hydroxynaphthalen-2-yl)-3-(pyridin-4-yl)prop-2-en-1-one
-
42.7% inhibition at 50 mM
(2E)-3-(2,4-dimethoxyphenyl)-1-(pyridin-2-yl)prop-2-en-1-one
-
12.3% inhibition at 50 mM
(2E)-3-(3,4-dihydroxyphenyl)-N-(2-phenylethyl)prop-2-enamide
-
-
(2E)-3-(3,4-dihydroxyphenyl)-N-(4-hydroxybenzyl)prop-2-enamide
-
-
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide
-
14% inhibition at 0.1 mM; 2% inhibition at 0.1 mM
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]prop-2-enamide
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]prop-2-enamide
-
-
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]prop-2-enamide
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-enamide
-
1% inhibition at 0.1 mM; 4% inhibition at 0.1 mM
(2E)-3-(3,4-dimethoxyphenyl)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]prop-2-enamide
-
-
(2E)-3-(4-chlorophenyl)-N-[2-(4-chlorophenyl)ethyl]prop-2-enamide
-
-
(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]prop-2-enamide
-
-
(2E)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-phenylethyl)prop-2-enamide
-
19% inhibition at 0.1 mM
(2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide
-
13% inhibition at 0.1 mM; 4% inhibition at 0.1 mM
(2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]prop-2-enamide
-
40% inhibition at 0.1 mM
(2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide
-
49% inhibition at 0.1 mM
(2E)-3-(4-hydroxyphenyl)-N-(2-phenylethyl)prop-2-enamide
-
strong tyrosinase inhibitory potential
(2E)-3-(4-hydroxyphenyl)prop-2-enoic acid
-
-
(2E)-3-(4-methoxyphenyl)-N-(1-phenylethyl)prop-2-enamide
-
-
(2E)-3-(4-methoxyphenyl)-N-(2-phenylethyl)prop-2-enamide
-
-
(2E)-3-(4-methoxyphenyl)prop-2-enoic acid
-
-
(2E)-3-phenyl-N-(1-phenylethyl)prop-2-enamide
-
-
(2E)-3-phenyl-N-(2-phenylethyl)prop-2-enamide
-
-
(2E)-3-phenylprop-2-enoic acid
-
-
(2E)-3-[4-(dimethylamino)phenyl]-1-(pyridin-2-yl)prop-2-en-1-one
-
16.9% inhibition at 50 mM
(2E)-but-2-enoic acid
-
non-competitive inhibition
(2E)-N-(3,4-dihydroxybenzyl)-3-(3,4-dihydroxyphenyl)prop-2-enamide
-
-
(2E)-N-(4-chlorobenzyl)-3-phenylprop-2-enamide
-
-
(2E)-N-benzyl-3-(3,4-dihydroxyphenyl)prop-2-enamide
-
-
(2E)-N-benzyl-3-(4-hydroxyphenyl)prop-2-enamide
-
strong tyrosinase inhibitory potential
(2E)-N-benzyl-3-(4-methoxyphenyl)prop-2-enamide
-
-
(2E)-N-benzyl-3-phenylprop-2-enamide
-
-
(2E)-N-[2-(3,4-dihydroxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
-
62% inhibition at 0.1 mM
(2E)-N-[2-(3,4-dimethoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
-
25% inhibition at 0.1 mM
(2E)-N-[2-(4-chlorophenyl)ethyl]-3-(4-hydroxyphenyl)prop-2-enamide
-
-
(2E)-N-[2-(4-chlorophenyl)ethyl]-3-phenylprop-2-enamide
-
-
(2E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(3-hydroxy-4-methoxyphenyl)prop-2-enamide
-
-
(2E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
(2E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxyphenyl)prop-2-enamide
-
-
(2E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-methoxyphenyl)prop-2-enamide
-
-
(2E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-phenylprop-2-enamide
-
-
(2E,4E)-hexa-2,4-dienoic acid
-
non-competitive inhibition
(2E,6E)-2,6-bis[(4-chlorophenyl)methylidene]cyclohexanone
-
-
(2E,6E)-2,6-bis[(4-hydroxyphenyl)methylidene]cyclohexanone
-
-
(2R,3R)-taxifolin
-
isolated from the sprout of Polygonum hydropiper L. (Benitade), inhibited 70% of tyrosinase activity at a concentration of 0.50 mM
(2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid
-
-
(2Z)-3-(3,4-dimethoxyphenyl)prop-2-enoic acid
-
-
(2Z)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid
-
-
(2Z)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid
-
-
(2Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid
-
-
(2Z)-3-(4-hydroxyphenyl)prop-2-enoic acid
-
-
(2Z)-3-(4-methoxyphenyl)prop-2-enoic acid
-
-
(2Z)-3-phenylprop-2-enoic acid
-
-
(4-oxo-2-[(1H-pyrrol-2-ylmethylene)-hydrazono]-thiazolidin-5-ylidene)-acetic acid methyl ester
-
-
(4-oxo-2-[(3-phenyl-allylidene)-hydrazono]-thiazolidin-5-ylidene)-acetic acid methyl ester
-
-
(7S, 8R, 8'R)-(-)-lariciresinol-4'-O-beta-D-glucopyranoside
-
tyrosinase inhibitors from Marrubium velutinum, lignan glucosides
(7S, 8R, 8'R)-(-)-lariciresinol-4,4'-O-bis-beta-D-glucopyranoside
-
tyrosinase inhibitors from Marrubium velutinum, lignan glucosides
(7S, 8R, 8'R)-(-)-lariciresinol-4-O-beta-D-glucopyranoside
-
tyrosinase inhibitors from Marrubium velutinum, lignan glucosides
(R)-HTCCA
(S)-HTCCA
(S)-imperanene
-
inhibitor in rum distillate wastewater significantly inhibits tyrosinase isolated from HMV-II cells, competitive inhibition. The inhibitory activities in descending order are (S)-imperanene 4-O-beta-D-glucopyranosyl imperanene, 4-O-beta-D-glucopyranosyl-3-methoxy imperanene
(Z)-2-(4-hydroxybenzylidene)-4-hydroxybenzofuran-3(2H)-one
-
71% inhibition at 0.1 mM
(Z)-2-(4-hydroxybenzylidene)-6-hydroxybenzofuran-3(2H)-one
-
69% inhibition at 0.1 mM
(Z)-2-(4-hydroxybenzylidene)benzofuran-3(2H)-one
-
39% inhibition at 0.1 mM
(Z)-4,6-dihydroxy-2-(4-hydroxybenzylidene)benzofuran-3(2H)-one
-
-
(Z)-4,6-dihydroxy-2-(4-methoxybenzylidene)benzofuran-3(2H)-one
-
11% inhibition at 0.1 mM
1,10-bis(1,10-carboxyethyl) ether
-
-
1,10-phenanthroline
-
1 mM, inactivation, half-life: 30 min
1,3-dimethylimidazolium methylsulfate
-
69.7% residual activity at 5% (w/v)
1,4-dithiothreitol
-
complete inhibition at 10 mM
1,5-bis(4-hydroxyphenyl)-1,4-pentadiene-3-one
-
-
1-(1,4-diacetylphenyl)dithiosemicarbazide
-
-
1-(1-(2,4,6-trihydroxyphenyl)ethylidene)thiosemicarbazide
-
-
1-(1-(2,4-dihydroxyphenyl)ethylidene)thiosemicarbazide
-
-
1-(1-(4-bromophenyl)ethylidene)thiosemicarbazide
-
-
1-(1-(4-fluorophenyl)ethylidene)thiosemicarbazide
-
-
1-(1-(4-hydroxyphenyl)ethylidene)thiosemicarbazide
-
-
1-(1-(4-isopropylphenyl)ethylidene)thiosemicarbazide
-
-
1-(1-(4-methoxyphenyl)ethylidene)thiosemicarbazide
-
-
1-(1-(4-methoxyphenyl)propan-2-ylidene)-thiosemicarbazide
-
-
1-(1-(4-methoxyphenyl)propan-2-ylidene)thiosemicarbazide
-
-
1-(1-(pyrazin-2-yl)ethylidene)thiosemicarbazide
-
-
1-(1-(pyridin-3-yl)ethylidene)thiosemicarbazide
-
-
1-(1-(thiophen-2-yl)ethylidene)thiosemicarbazide
-
-
1-(1-p-tolylethylidene)thiosemicarbazide
-
-
1-(1-phenylethylidene)thiosemicarbazide
-
-
1-(2,4-dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)propane
1-(2,4-dimethoxyphenyl)-3-hydroxyurea
-
-
1-(2,5-dimethyl-1H-pyrrol-1-yl)thiourea
-
-
1-(2-hydroxy-1,2-diphenylethylidene)thiosemicarbazide
-
-
1-(2-oxo-1,2-diphenylethylidene)thiosemicarbazide
-
-
1-(3-methylbutylidene)thiosemicarbazide
-
-
1-(3-oxocyclohexylidene)thiosemicarbazide
-
-
1-(3-phenylallylidene)thiosemicarbazide
-
-
1-(4-(4-hydroxyphenyl)butan-2-ylidene)-thiosemicarbazide
-
-
1-(4-(4-hydroxyphenyl)butan-2-ylidene)thiosemicarbazide
-
-
1-(4-bromophenyl)-3-hydroxyurea
-
-
1-(4-butoxyphenyl)-3-hydroxyurea
-
-
1-(4-fluorophenyl)-ethanone
-
-
1-(4-methoxyphenyl)-ethanone
-
-
1-(4-methylpent-3-en-2-ylidene) thiosemicarbazide
-
-
1-(but-2-enylidene)thiosemicarbazide
-
-
1-(butan-2-ylidene)thiosemicarbazide
-
-
1-(propan-2-ylidene)thiosemicarbazide
1-(thiophen-2-yl)-ethanone
-
-
1-butyl-3-methylimidazolium methylsulfate
-
47.8% residual activity at 5% (w/v)
1-cyclohexylidenethiosemicarbazide
-
-
1-cyclopentyl-1-hydroxy-2-oxohydrazine
-
inhibition of the diphenolase activity of mushroom tyrosinase over the pH range of 5.5-8.0 is studied
1-cyclopentylidenethiosemicarbazide
-
-
1-dodecyl-1-hydroxy-2-oxohydrazine
-
inhibition of the diphenolase activity of mushroom tyrosinase over the pH range of 5.5-8.0 is studied
1-ethyl-3-methylimidazolium ethyl sulfate
in the presence of 10 or 20% (w/v) 1-ethyl-3-methylimidazolium ethyl sulfate, the activity decreases dramatically and becomes negligible
1-ethyl-3-methylimidazolium methylsulfate
-
64.1% residual activity at 5% (w/v)
1-ethylidenethiosemicarbazide
-
-
1-hydroxy-1,3-dimethyl-3-phenylurea
-
-
1-hydroxy-1-methyl-3-(4-nitrophenyl)urea
-
-
1-hydroxy-1-methyl-3-phenylurea
-
-
1-hydroxy-1-naphthalen-1-yl-2-oxohydrazine
-
inhibition of the diphenolase activity of mushroom tyrosinase over the pH range of 5.5-8.0 is studied
1-hydroxy-2-oxo-1-phenylhydrazine
-
inhibition of the diphenolase activity of mushroom tyrosinase over the pH range of 5.5-8.0 is studied
1-hydroxy-3-(4-hydroxyphenyl)urea
-
-
1-hydroxy-3-(4-methoxyphenyl)urea
-
-
1-hydroxy-3-(4-nitrophenyl)urea
-
-
1-hydroxy-3-phenylthiourea
-
-
1-hydroxy-3-phenylurea
-
also retains a substantial potency in cell culture by reducing pigment synthesis by 78%
1-hydroxy-3-[4-(trifluoromethyl)phenyl]urea
-
-
1-methoxy-3-(4-nitrophenyl)thiourea
-
-
1-methoxy-3-naphthalen-2-ylthiourea
-
-
1-methoxy-3-phenylurea
-
-
1-methylethyl (2E)-3-(5-hydroxy-4-oxo-4H-pyran-2-yl)prop-2-enoate
-
-
1-pentanoyl-3-(2,3-dichlorophenyl)thiourea
-
-
1-pentanoyl-3-(2,4,6-trimethylphenyl)thiourea
-
-
1-pentanoyl-3-(2,4-dinitrophenyl)thiourea
-
-
1-pentanoyl-3-(2,6-dibromo-4-fluorophenyl)thiourea
-
-
1-pentanoyl-3-(3-nitrophenyl)thiourea
-
-
1-pentanoyl-3-(4-bromo-2-fluorophenyl)thiourea
-
-
1-pentanoyl-3-(4-bromophenyl)thiourea
-
-
1-pentanoyl-3-(4-chlorophenyl)thiourea
-
-
1-pentanoyl-3-(4-methoxyphenyl)thiourea
-
noncompetitive inhibition, docking interaction analysis between 1-pentanoyl-3-(4-methoxyphenyl)thiourea and mushroom tyrosinase
1-pentanoyl-3-(4-nitrophenyl)thiourea
-
-
1-Phenyl-2-thiourea
1-propylidenethiosemicarbazide
-
-
1-[1-(4-methoxyphenyl)ethylidene]thiosemicarbazide
-
-
1-[4-(benzyloxy)phenyl]-3-hydroxyurea
-
-
1-[[tert-butyl(dimethyl)silyl]oxy]-3-phenylurea
-
-
1H-indol-5-ol
-
54% inhibition at 0.1 mM; 62% inhibition at 0.1 mM
2'-(3,4-dihydroxyphenyl)-3',5,5',7,7'-pentahydroxy-2-(4-hydroxyphenyl)-2,2',3,3',4a,8a-hexahydro-4H,4'H-3,8'-bichromene-4,4'-dione
-
most potent inhibitor
2,2':4',2''-ter-1,3,4-oxadiazole-5,5',5''(4H,4''H)-trithione
-
-
2,2':4',2''-ter-1,3,4-thiadiazole-5,5',5''(4H,4''H)-trithione
-
-
2,3,4'-trihydroxy-4-methoxydeoxybenzoin
-
displays stable and significant inhibitory effect on tyrosinase activity
2,3,4,4'-tetrahydroxydeoxybenzoin
-
-
2,3,4-trihydroxy-3',4'-dimethoxydeoxybenzoin
-
-
2,3,4-trihydroxy-4'-methoxydeoxybenzoin
-
-
2,3-dimercapto-1-propanol
-
2 mM, 93% inhibition
2,4,4',6-tetrahydroxydeoxybenzoin
-
-
2,4,4'-trihydroxydeoxybenzoin
-
-
2,4,5-trihydroxy-4'-methoxydeoxybenzoin
-
-
2,4,6-cycloheptatriene-1-one
2,4,6-trihydroxy-4'-methoxydeoxybenzoin
-
-
2,4-dichlorocinnamic acid
-
-
2,4-dihydroxy-3',4'-dimethoxydeoxybenzoin
-
-
2,4-dihydroxy-4'-methoxydeoxybenzoin
-
-
2,4-dihydroxy-N-(3,4,5-trihydroxybenzyl)benzamide
-
IC50: 0.550 mM
2,4-dihydroxy-N-(4-hydroxybenzyl)benzamide
-
IC50: 1.820 mM
2,4-dihydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
39% inhibition at 0.1 mM; 50% inhibition at 0.1 mM
2,5-dihydroxybenzoic acid
-
-
2-(2-furanylmethylene)-thiosemicarbazone
-
-
2-(2-hydroxyethoxy)ethyl (2E)-3-(5-hydroxy-4-oxo-4H-pyran-2-yl)prop-2-enoate
-
-
2-(2-methoxyethoxy)ethyl (2E)-3-(5-hydroxy-4-oxo-4H-pyran-2-yl)prop-2-enoate
-
-
2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl 3,4,5-trihydroxybenzoate
-
mixed-type inhibitor
2-(3,4-dihydroxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]acetamide
-
34% inhibition at 0.1 mM
2-(4-fluorophenyl)-quinazolin-4(3H)-one
-
synthesis of the tyrosinase inhibitor, inhibits the diphenolase activity of tyrosinase. Structure analysis by 1H and 13C NMR spectroscopy, Fourier transform infrared spectroscopy (FTIR), and high resolution mass spectrometry. Molecular docking simulation analysis and inhibition mechanism, a mixed-type inhibitor exerting reversible inhibition, overview. The inhibitor does not reduce the amount of the enzyme, but decreases the enzyme activity for the oxidation of L-dopa
2-(4-formyl-2-methoxyphenoxy)-2-oxoethyl (2E)-3-(4-chlorophenyl)prop-2-enoate
-
mixed-type inhibition
2-(4-formyl-2-methoxyphenoxy)-2-oxoethyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate
-
reversible, mixed-type inhibition
2-(4-formyl-2-methoxyphenoxy)-2-oxoethyl 2,4-dihydroxybenzoate
-
mixed-type inhibition
2-(4-formyl-2-methoxyphenoxy)-2-oxoethyl 3,4-dihydroxybenzoate
-
-
2-(4-formyl-2-methoxyphenoxy)-2-oxoethyl 3,5-dihydroxybenzoate
-
-
2-(4-formyl-2-methoxyphenoxy)-2-oxoethyl 4-hydroxybenzoate
-
-
2-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]acetamide
-
16% inhibition at 0.1 mM
2-(chloromethyl)-10-(2-fluorophenyl)-7,7-dimethyl-6,7,8,10-tetrahydropyrano[3,2-b]chromene-4,9-dione
-
-
2-(chloromethyl)-10-(4-fluorophenyl)-7,7-dimethyl-6,7,8,10-tetrahydropyrano[3,2-b]chromene-4,9-dione
-
i.e. DHPC04, binding mode of R-DHPC04 and S-DHPC04 on the catalytic site of the enzyme, interactions between DHPC04 and residues His243 and Asn260
2-(hydroxymethyl)-7,7-dimethyl-10-phenyl-6,7,8,10-tetrahydropyrano[3,2-b]chromene-4,9-dione
-
weak inhibition
2-(phenylmethylene)-thiosemicarbazone
-
-
2-acetylamino-1,3,4-thiadiazole-5-sulfonamide
2-butyl-5-hydroxyphenyl 3-(3,4-dihydroxyphenyl)propanoate
2-chlorobenzaldehyde thiosemicarbazone
-
exhibits significant inhibitory potency on both monophenolase activity and diphenolase activity of tyrosinase, reversible noncompetitive inhibitor
2-chlorocinnamic acid
-
-
2-chlorophenol
-
competitive inhibitor
2-cyano-4-hydroxycinnamic acid
-
-
2-ethyl-3-hydroxy-4H-pyran-4-one
-
-
2-hydroxy-4-methoxybenzoic acid
-
-
2-hydroxy-4-methylbenzoic acid
-
-
2-hydroxy-5-methoxybenzoic acid
-
-
2-hydroxy-5-methylbenzoic acid
-
-
2-Hydroxybenzaldehyde
-
-
2-hydroxybenzoic acid
2-hydroxyethyl (2E)-3-(5-hydroxy-4-oxo-4H-pyran-2-yl)prop-2-enoate
-
-
2-mercaptoethanol
2-methoxyethyl (2E)-3-(5-hydroxy-4-oxo-4H-pyran-2-yl)prop-2-enoate
-
-
2-Methylbenzaldehyde
-
-
2-Methylbenzoic acid
-
-
2-Methylresorcinol
-
acts as enzyme substrate and inhibitor
2-oxoglutaric acid
-
AKG, a reversible inhibitor of tyrosinase, inhibition kinetics integrated with molecular dynamics simulations reveal a complex induced parabolic slope mixed-type inhibition. AKG significantly inhibits the L-dopa oxidation of tyrosinase in a dose-dependent manner, complete inactivation at about 25 mM. Enzyme residues His85, His259, Asn260, Phe264, Met280, Gly281, and Val283 interact with the inhibitor
2-[(1E,2E)-N-hydroxy-3-(pyridin-2-yl)prop-2-enimidoyl]phenol
-
77.5% inhibition at 50 mM, reversible competitive inhibition
2-[(1E,2E)-N-hydroxy-3-(pyridin-3-yl)prop-2-enimidoyl]phenol
-
80.6% inhibition at 50 mM, reversible competitive inhibition
2-[(1E,2E)-N-hydroxy-3-(pyridin-4-yl)prop-2-enimidoyl]phenol
-
69.8% inhibition at 50 mM
2-[(2,3,4-trihydroxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(2,4-dihydroxyphenyl)methylene]-thiosemicarbazone
-
most potent tyrosinase inhibitor
2-[(2,5-dihydroxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(2,5-dimethoxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(2-hydroxy-4-bromophenyl)methylene]thiosemicarbazone
-
-
2-[(2-hydroxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(3,4,5-trihydroxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(3,4,5-trimethoxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(3,4-dihydroxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(3,5-dihydroxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(3-hydroxy-4-methoxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(3-hydroxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(3-methoxy-4-hydroxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(4-bromophenyl)methylene]-thiosemicarbazone
-
-
2-[(4-hydroxyphenyl)methylene]-thiosemicarbazone
-
-
2-[(4-methoxyphenyl)methylene]-thiosemicarbazone
-
-
2-[2-(2,4-dihydroxyphenyl)ethyl]-5-(D-xylopyranosyloxy)phenyl D-xylopyranoside
-
isolated from Chlorophytum arundinaceum (liliaceae)
2-[2-(2,4-dihydroxyphenyl)ethyl]-5-hydroxyphenyl D-xylopyranoside
-
isolated from Chlorophytum arundinaceum (liliaceae)
2-[2-(2-hydroxyethoxy)ethoxy]ethyl (2E)-3-(5-hydroxy-4-oxo-4H-pyran-2-yl)prop-2-enoate
-
-
2-[2-(2-methoxyethoxy)ethoxy]ethyl (2E)-3-(5-hydroxy-4-oxo-4H-pyran-2-yl)prop-2-enoate
-
-
2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl (2E)-3-(2,4-dihydroxyphenyl)prop-2-enoate
non-competitive inhibitor, binding to the enzyme's binuclear active site is irreversible. The 2-hydroxy group in the compound interacts with amino acid HIS85 which is present in active binding site
2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl (2E)-3-(4-chlorophenyl)prop-2-enoate
-
2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate
mixed-type inhibition
2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl (2E)-3-phenylprop-2-enoate
-
2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl 2,4-dihydroxybenzoate
mixed-type inhibition
2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl 3,4,5-trihydroxybenzoate
-
2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl 3,4-dihydroxybenzoate
-
2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl 3,5-dihydroxybenzoate
-
2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl 3-hydroxybenzoate
-
2-[2-methyl-5-(propan-2-yl)phenoxy]-2-oxoethyl 4-hydroxybenzoate
-
2-[3-(2,4-dimethoxy-3-methylphenyl)propyl]benzene-1,4-diol
-
plant-derived diarylpropane tyrosinase inhibitor
2alpha,3alpha,23-trihydroxyolean-12-en-28-oic acid
-
pentacyclic triterpene extracted from Rhododendron collettianum
3'',4''-dihydroglabridin
-
100% inhibition at 0.33 mg/ml
3',5,5',7,7'-pentahydroxy-2,2'-bis(4-hydroxyphenyl)-2,2',3,3',4a,8a-hexahydro-4H,4'H-3,8'-bichromene-4,4'-dione
-
-
3,4,5-trihydroxy-N-(3,4,5-trihydroxybenzyl)benzamide
-
IC50: 0.555 mM
3,4,5-trihydroxy-N-(4-hydroxybenzyl)benzamide
-
IC50: 1.180 mM
3,4-dihydroxy-4'-methoxydeoxybenzoin
-
-
3,4-dihydroxy-N-(3,4,5-trihydroxybenzyl)benzamide
-
IC50: 0.280 mM
3,4-dihydroxy-N-(4-hydroxybenzyl)benzamide
-
IC50: 2.0 mM
3,4-dihydroxy-N-[2-(1H-indol-3-yl)ethyl]benzamide
-
2% inhibition at 0.1 mM; 7% inhibition at 0.1 mM
3,4-dihydroxy-N-[2-(4-hydroxyphenyl)ethyl]benzamide
-
6% inhibition at 0.1 mM; 9% inhibition at 0.1 mM
3,4-dihydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
43% inhibition at 0.1 mM; 48% inhibition at 0.1 mM
3,4-dihydroxybenzaldehyde-O-ethyloxime
-
-
3,4-dihydroxybenzoic acid
3,4-dihydroxycinnamic acid
-
noncompetitive inhibition
3,4-dimethoxycinnamic acid
-
2.5% inhibition at 0.33 mM
3,4-dimethoxydihydrocinnamic acid
-
20.2% inhibition at 1 mM
3,5-dihydroxy-N-(3,4,5-trihydroxybenzyl)benzamide
-
IC50: 0.705 mM
3,5-dihydroxy-N-(4-hydroxybenzyl)benzamide
-
IC50: 0.710 mM
3,7,3',4'-taxifolin tetraacetate
-
assayed together with (2R,3R)-taxifolin
3-(2-aminoethyl)-1H-indol-5-ol
-
15% inhibition at 0.1 mM; 22% inhibition at 0.1 mM
3-(3',4',5'-trihydroxyphenyl)-6,8-dihydroxycoumarin
-
potent, non-competitive tyrosinase inhibitor, 68.3% inhibition at 0.8 mM
3-(3,4-dihydroxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]propanamide
-
94% inhibition at 0.1 mM
3-(3-hydroxyphenyl)-2H-chromen-2-one
-
19.3% inhibition at 0.8 mM
3-(4-bromophenyl)-1-hydroxy-1-methylurea
-
-
3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]propanamide
-
28% inhibition at 0.1 mM
3-(4-hydroxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]propanamide
-
96% inhibition at 0.1 mM
3-hydroxy-1,2-dimethyl-4(1H)-pyridone
-
-
3-hydroxy-1-methyl-1-phenylurea
-
-
3-Hydroxybenzaldehyde
-
-
3-hydroxycinnamic acid
3-hydroxycoumarin
-
-
3-hydroxyphloretin
3-hydroxyphloridzin
-
-
3-methoxy-1-methyl-1-phenylurea
-
-
3-Methoxybenzaldehyde
-
-
3-methylbenzaldehyde
-
-
3-methylbenzoic acid
-
-
3-methylcrotonic acid
-
-
3-O-[2,6-di-O-alpha-L-rhamnopyranosyl-beta-D-galactopyranosyl]-quercetin
-
from Guioa villosa leaf extract
3-[(1E,2E)-N-hydroxy-3-(pyridin-2-yl)prop-2-enimidoyl]naphthalen-2-ol
-
58.2% inhibition at 50 mM
3-[(1E,2E)-N-hydroxy-3-(pyridin-3-yl)prop-2-enimidoyl]naphthalen-2-ol
-
62.6% inhibition at 50 mM
3-[(1E,2E)-N-hydroxy-3-(pyridin-4-yl)prop-2-enimidoyl]naphthalen-2-ol
-
57.5% inhibition at 50 mM
3beta, 23, 24-trihydroxyolean-12-en-28-oic acid
-
pentacyclic triterpene extracted from Rhododendron collettianum
4'-hydroxy-[1,1'-biphenyl]-2-carboxylic acid
-
-
4'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
-
-
4'-hydroxy-[1,1'-biphenyl]-4-carboxylic acid
-
binding mode, modeling
4'-methoxy-[1,1'-biphenyl]-2-carboxylic acid
-
-
4'-methoxy-[1,1'-biphenyl]-3-carboxylic acid
-
-
4'-methoxy-[1,1'-biphenyl]-4-carboxylic acid
-
binding mode, modeling
4,4'-diamino-3-(4-hydroxyphenyl)-1'H-1,3'-bi-1,2,4-triazole-5,5'(4H,4'H)-dithione
-
-
4,4'-diamino-3-(pyridin-4-yl)-1'H-1,3'-bi-1,2,4-triazole-5,5'(4H,4'H)-dithione
-
-
4,4'-ethane-1,2-diyldibenzene-1,3-diol
-
-
4,6,4'-trihydroxyaurone
-
75% inhibition at 0.1 mM
4-(1-methylethyl)benzaldehyde
-
-
4-(1-methylethyl)benzoic acid
-
-
4-(2-(hydroxymethyl)-7,7-dimethyl-4,9-dioxo-4,6,7,8,9,10-hexahydropyrano[3,2-b]chromen-10-yl)benzonitrile
-
-
4-(benzyloxy)-N'-(hydrazinylcarbonyl)benzohydrazide
-
-
4-(hexyloxy)benzoic acid
-
-
4-(pentyloxy)benzoic acid
-
-
4-Aminobenzoic acid
4-butoxybenzoic acid
-
-
4-butylbenzaldehyde
-
-
4-butylbenzoic acid
4-chlorobenzaldehyde thiosemicarbazone
-
exhibits significant inhibitory potency on both monophenolase activity and diphenolase activity of tyrosinase, reversible mixed-type inhibitor
4-chlorosalicylic acid
-
-
4-coumaric acid
-
74.4% inhibition at 0.33 mM
4-dodecylresorcinol
-
reversible and competitive inhibition, IC50: 0.00112 mM
4-ethenylbenzaldehyde
-
-
4-ethenylbenzoic acid
-
-
4-ethoxybenzoic acid
-
-
4-Ethylbenzaldehyde
-
-
4-ethylbenzoic acid
-
-
4-ethylresorcinol
-
acts as enzyme substrate and inhibitor
4-formyl-2-methoxyphenyl (4-methylpiperazin-1-yl)acetate
-
reversible, non-competitive inhibition
4-formyl-2-methoxyphenyl (4-phenylpiperazin-1-yl)acetate
-
-
4-formyl-2-methoxyphenyl chloroacetate
-
-
4-formylphenyl 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranoside
-
-
4-formylphenyl 2,3,4-tri-O-acetyl-beta-D-allopyranoside
-
-
4-formylphenyl 2,3,4-tri-O-benzyl-beta-D-ribopyranoside
-
-
4-formylphenyl 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)-beta-D-glucopyranoside
-
-
4-formylphenyl 2,3-O-(1-methylethylidene)-beta-D-allopyranoside
-
-
4-formylphenyl 4,6-O-(phenylmethylidene)-beta-D-gulopyranoside
-
-
4-formylphenyl 6-O-(dimethoxyphosphoryl)-beta-D-allopyranoside
-
-
4-formylphenyl 6-O-trityl-beta-D-allopyranoside
-
-
4-formylphenyl beta-D-allopyranoside
-
-
4-formylphenyl beta-D-glucopyranoside
-
-
4-formylphenyl beta-D-ribopyranoside
-
-
4-formylphenyl-O-beta-D-allopyranoside
-
-
4-heptylbenzaldehyde
-
-
4-heptylbenzoic acid
4-hexylbenzaldehyde
-
-
4-hexylbenzoic acid
4-hexylresorcinol
4-hydroxy-3-methoxycinnamic acid
-
noncompetitive inhibition
4-hydroxy-N-[2-(1H-indol-3-yl)ethyl]benzamide
-
0% inhibition at 0.1 mM
4-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-methoxybenzamide
-
16% inhibition at 0.1 mM; 32% inhibition at 0.1 mM
4-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
31% inhibition at 0.1 mM; 9% inhibition at 0.1 mM
4-hydroxyanisole
-
can also act as enzyme substrate
4-hydroxybenzaldehyde
4-hydroxybenzoic acid
4-Hydroxybenzyl alcohol
-
the compound is a substrate and an inhibitor for tyrosinase, 39% inhibition at 1.5 mM
4-hydroxycinnamic acid
4-Hydroxycoumarin
-
weak inhibition
4-hydroxyphenyl beta-D-xyloside
-
-
4-hydroxyphenyl beta-xylodioside
-
competitive inhibitor
4-hydroxyphenyl beta-xylotetraoside
-
competitive inhibitor, shows 35fold more potent inhibitory activity than beta-arbutin
4-hydroxyphenyl beta-xylotrioside
-
competitive inhibitor
4-methoxybenzaldehyde
-
-
4-methoxybenzoic acid
-
-
4-methoxycinnamic acid
4-methylbenzaldehyde
-
-
4-methylbenzoic acid
-
-
4-methylcatechol
4-methylresorcinol
-
acts as enzyme substrate and inhibitor
4-n-butylresorcinol
-
-
4-nitrophenol
-
competitive to catechol
4-O-beta-D-glucopyranosyl imperanene
-
inhibitor in rum distillate wastewater significantly inhibits tyrosinase isolated from HMV-II cells. The inhibitory activities in descending order are (S)-imperanene, 4-O-beta-D-glucopyranosyl imperanene, 4-O-beta-D-glucopyranosyl-3-methoxy imperanene
4-O-beta-D-glucopyranosyl-3-methoxy imperanene
-
inhibitor in rum distillate wastewater significantly inhibits tyrosinase isolated from HMV-II cells. The inhibitory activities in descending order are (S)-imperanene, 4-O-beta-D-glucopyranosyl imperanene, 4-O-beta-D-glucopyranosyl-3-methoxy imperanene
4-octylbenzaldehyde
-
-
4-octylbenzoic acid
4-OH-cinnamic acid
-
4% inhibition at 0.1 mM
4-pentylbenzaldehyde
-
-
4-pentylbenzoic acid
4-phenyl-2-butanol
-
a reversible, potent inhibitor of tyrosinase, mixed-type inhibitor fothe monophenoase activity and noncompetitive-type inhibitor for the diphenolase activity
4-propoxybenzoic acid
-
-
4-propylbenzaldehyde
-
-
4-propylbenzoic acid
4-tert-butylbenzaldehyde
-
-
4-tert-butylbenzoic acid
-
-
4-xylidine-bis(dithiocarbamate) sodium salt
-
Na-SSC-NH-CH2-C6H4-CH2-NH-CSS-Na, mixed-type inhibition for both, catecholase and cresolase activities
4-[(1E,3E)-3-(hydroxyimino)-3-(pyridin-2-yl)prop-1-en-1-yl]-N,N-dimethylaniline
-
50.6% inhibition at 50 mM
4-[(E)-(carbamothioylhydrazono)methyl]phenyl 2,3,4,6-tetra-O-acetyl-beta-D-allopyranoside
-
-
4-[(E)-(carbamothioylhydrazono)methyl]phenyl 2,3,4,6-tetra-O-acetyl-beta-D-galactopyranoside
-
-
4-[(E)-(carbamothioylhydrazono)methyl]phenyl 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranoside
-
-
4-[(E)-(carbamothioylhydrazono)methyl]phenyl 2,3,4,6-tetrakis-O-(phenylcarbonyl)-beta-D-glucopyranoside
-
-
4-[(E)-(carbamothioylhydrazono)methyl]phenyl 2,3,4-tris-O-(phenylcarbonyl)-beta-D-xylopyranoside
-
-
4-[(E)-(carbamothioylhydrazono)methyl]phenyl 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)-beta-D-glucopyranoside
-
-
4-[(E)-(carbamothioylhydrazono)methyl]phenyl beta-D-allopyranoside
-
-
4-[(E)-(carbamothioylhydrazono)methyl]phenyl beta-D-glucopyranoside
-
-
4-[(E)-(hydroxyimino)methyl]phenyl 2,3,4,6-tetra-O-acetyl-beta-D-allopyranoside
-
reversible and competitive-type inhibitor
4-[(E)-(hydroxyimino)methyl]phenyl 2,3,4,6-tetra-O-acetyl-beta-D-galactopyranoside
-
-
4-[(E)-(hydroxyimino)methyl]phenyl 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranoside
-
-
4-[(E)-(hydroxyimino)methyl]phenyl 2,3,4,6-tetrakis-O-(phenylcarbonyl)-beta-D-glucopyranoside
-
-
4-[(E)-(hydroxyimino)methyl]phenyl 2,3,4-tris-O-(phenylcarbonyl)-beta-D-xylopyranoside
-
-
4-[(E)-(hydroxyimino)methyl]phenyl 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)-beta-D-glucopyranoside
-
-
4-[(E)-(hydroxyimino)methyl]phenyl beta-D-allopyranoside
-
-
4-[(E)-(hydroxyimino)methyl]phenyl beta-D-glucopyranoside
-
-
4-[(E)-(methoxyimino)methyl]phenyl 2,3,4,6-tetra-O-acetyl-beta-D-allopyranoside
-
-
4-[(E)-(methoxyimino)methyl]phenyl 2,3,4,6-tetra-O-acetyl-beta-D-galactopyranoside
-
-
4-[(E)-(methoxyimino)methyl]phenyl 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranoside
-
-
4-[(E)-(methoxyimino)methyl]phenyl 2,3,4,6-tetrakis-O-(phenylcarbonyl)-beta-D-glucopyranoside
-
-
4-[(E)-(methoxyimino)methyl]phenyl 2,3,4-tris-O-(phenylcarbonyl)-beta-D-xylopyranoside
-
-
4-[(E)-(methoxyimino)methyl]phenyl 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)-beta-D-glucopyranoside
-
-
4-[(E)-(methoxyimino)methyl]phenyl beta-D-allopyranoside
-
-
4-[(E)-(methoxyimino)methyl]phenyl beta-D-glucopyranoside
-
-
4-[2-(2,4-dihydroxyphenyl)ethyl]-3-hydroxyphenyl D-xylopyranoside
-
isolated from Chlorophytum arundinaceum (liliaceae)
4-[3-(2-hydroxy-5-methoxyphenyl)propyl]benzene-1,3-diol
-
plant-derived diarylpropane tyrosinase inhibitor
4-[[hydroxy(nitroso)amino]methyl]benzene-1,3-diol
-
inhibition of the diphenolase activity of mushroom tyrosinase over the pH range of 5.5-8.0 is studied
4-[[hydroxy(nitroso)amino]methyl]phenol
-
inhibition of the diphenolase activity of mushroom tyrosinase over the pH range of 5.5-8.0 is studied
5'-(3-hydroxyphenyl)-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-(4-hydroxyphenyl)-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-(4-hydroxyphenyl)-2,3'-bi-1,3,4-thiadiazole-2',5(4H)-dithione
-
-
5'-(4-[[tert-butyl(dimethyl)silyl]oxy]phenyl)-2,3'-bi-1,3,4-thiadiazole-2',5(4H)-dithione
-
-
5'-(diphenylmethyl)-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-(diphenylmethyl)-2,3'-bi-1,3,4-thiadiazole-2',5(4H)-dithione
-
-
5'-(naphthalen-1-yl)-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-(pyridin-4-yl)-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-(pyridin-4-yl)-2,3'-bi-1,3,4-thiadiazole-2',5(4H)-dithione
-
-
5'-benzyl-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-cyclohexyl-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-phenyl-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-phenyl-2,3'-bi-1,3,4-thiadiazole-2',5(4H)-dithione
-
-
5'-[(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)methyl]-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-[(5-thioxo-4,5-dihydro-1,3,4-thiadiazol-2-yl)methyl]-2,3'-bi-1,3,4-thiadiazole-2',5(4H)-dithione
-
-
5'-[3-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)propyl]-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-[3-(benzyloxy)phenyl]-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5'-[4-(benzyloxy)phenyl]-2,3'-bi-1,3,4-oxadiazole-2',5(4H)-dithione
-
-
5,2',4'-trihydroxy-2'',2''-dimethylchromene-(6,7:5'',6'')-flavanone
-
dalenin, the reversible inhibitor is 52 and 495times more effective as a monophenolase inhibitor than hydroquinone and kojic acid, respectively, non-competitive inhibitor with L-DOPA as substrate, mixed-I type inhibitor with L-tyrosine as substrate
5,5',7,7'-tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-2,2',3,3',4a,8a-hexahydro-4H,4'H-3,8'-bichromene-4,4'-dione
-
-
5,5',7-trihydroxy-2,2'-bis(4-hydroxyphenyl)-4,4'-dioxo-3,3',4,4',4a,8a-hexahydro-2H,2'H-3,8'-bichromen-7'-yl D-glucopyranoside
-
tyrosinase inhibitor isolated from extracts of the seeds of Garcinia kola
5,6,7,4'-tetramethylscutellarein
-
tyrosinase inhibitors from Marrubium velutinum, flavones/flavonols. Methoxylated flavones, like the methylethers of scutellarein, showed 10times lower inhibitory activity than kojic acid
5,6,7,8,4'-pentahydroxyflavone
-
tyrosinase inhibitors from Marrubium cylleneum, flavones/flavonols
5,7,3',4'-taxifolin teramethyl ether
-
assayed together with (2R,3R)-taxifolin
5,7,4'-trimethylscutellarein
-
tyrosinase inhibitors from Marrubium velutinum, flavones/flavonols. Methoxylated flavones, like the methylethers of scutellarein, showed 10times lower inhibitory activity than kojic acid
5-(4-(2-(2-methoxyethoxy)ethoxy)benzyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
97.49% inhibition at 0.2 mM
5-(4-(2-(2-methoxyethoxy)ethoxy)benzyl)pyrimidine-2,4,6(1H,3H,5H)trione
-
14.3% inhibition at 0.2 mM
5-(4-(2-(2-methoxyethoxy)ethoxy)benzylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
complete inhibition at 0.2 mM
5-(4-(2-(2-methoxyethoxy)ethoxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione
-
88.67% inhibition at 0.2 mM
5-(4-(2-butoxyethoxy)benzyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
78.67% inhibition at 0.2 mM
5-(4-(2-butoxyethoxy)benzylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
85.88% inhibition at 0.2 mM
5-(4-(2-butoxyethoxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione
-
complete inhibition at 0.2 mM
5-(4-(2-hydroxyethoxy)benzyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
95.86% inhibition at 0.2 mM
5-(4-(2-hydroxyethoxy)benzyl)pyrimidine-2,4,6(1H,3H,5H)-trione
-
5.27% inhibition at 0.2 mM
5-(4-(2-hydroxyethoxy)benzylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
16.54% inhibition at 0.2 mM
5-(4-(2-hydroxyethoxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione
-
22.41% inhibition at 0.2 mM
5-(4-(2-methoxyethoxy)benzyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
complete inhibition at 0.2 mM
5-(4-(2-methoxyethoxy)benzyl)pyrimidine-2,4,6(1H,3H,5H)-trione
-
23.12% inhibition at 0.2 mM
5-(4-(2-methoxyethoxy)benzylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
complete inhibition at 0.2 mM
5-(4-(2-methoxyethoxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione
-
complete inhibition at 0.2 mM
5-(4-(4-methoxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione
-
12.2% inhibition at 0.2 mM
5-(4-(4-methoxybutoxy)benzyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
9.85% inhibition at 0.2 mM
5-(4-(4-methoxyethoxy)benzyl)pyrimidine-2,4,6(1H,3H,5H)-trione
-
1.15% inhibition at 0.2 mM
5-(4-(4-methoxyethoxy)benzylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
complete inhibition at 0.2 mM
5-(4-hydroxybenzyl)-2-thioxo-dihydropyrimidine-4,6(1H,5H)-dione
-
complete inhibition at 0.2 mM
5-(4-hydroxybenzyl)pyrimidine-2,4,6(1H,3H,5H)-trione
-
47.5% inhibition at 0.2 mM
5-(4-hydroxybenzylidene)-2-thioxo-dihydropyrimidine-4,6(1H,5H)-dione
-
complete inhibition at 0.2 mM
5-(4-hydroxybenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione
-
complete inhibition at 0.2 mM
5-ethenyl-5-hydroxy-3-isocyanocyclopent-2-en-1-one
-
inhibitor produced by Trichoderma viride strain H1-7 from a marine environment. Competitive inhibition
5-hydroxy-2-(hydroxymethyl)-2H-pyran-4-one
5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one
5-hydroxy-4-oxo-4H-pyran-2-carboxylic acid
-
-
5-hydroxyindole
-
-
5-hydroxymethyl-2-furfural
-
noncompetitive inhibition
5-hydroxytryptophan
-
-
5-methyl-1,3-benzenediol
-
competitive to catechol
6'-glucosyl-martynoside
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides. Bathochromic shift of 6'-glucosyl-martynoside in the presence of CuSO4 (0.05 mM)
6-hydroxy-2H-pyran-3-carbaldehyde
-
a new tyrosinase inhibitor from Crinum yemense, testing for tyrosinase inhibiting activity, based on structural similarity to kojic acid. It shows a concentration-dependant reduction in tyrosinase activity similar to kojic acid in an in vitro assay, more potent than kojic acid
6-hydroxy-3-(4'-hydroxyphenyl)coumarin
-
26.7% inhibition at 0.8 mM
6-hydroxy-kaempferol-3-O-rutinoside
-
tyrosinase inhibitors from Marrubium velutinum, flavone/flavonol glucosides
6-hydroxyapigenin
-
5,6,7-trihydroxyflavone, high inhibitory effects on tyrosinase. Acts as a cofactor to monophenolase
6-hydroxycoumarin
-
weak inhibition
6-hydroxygalangin
-
5,6,7-trihydroxyflavone, high inhibitory effects on tyrosinase. Acts as a cofactor to monophenolase
6-hydroxykaempferol
-
5,6,7-trihydroxyflavone, high inhibitory effects on tyrosinase. Acts as a cofactor to monophenolase. competitive inhibitor
7-(2,4-dihydroxyphenyl)-4-hydroxy-2-(2-hydroxypropan-2-yl)-2,3-dihydrofuro(3,2-g)chromen-5-one
-
artocarpfuranol, isolated from the wood of Artocarpus heterophyllus, strong mushroom tyrosinase inhibitory activity
7-hydroxy-3-(4-hydroxyphenyl)-2H-chromen-2-one
-
9.6% inhibition at 0.8 mM
7-hydroxycoumarin
-
-
8-hydroxyquinoline
8-isoprenyl-5'-geranyl-5,7,2',4'-tetrahydroxy flavanone
-
competitive inhibitor
8-O-methyltianmushanol
-
-
9-hydroxy-4-methoxypsoralen
-
noncompetitive inhibition
Ac-KSRFR
-
N-acetyl-pentapeptide Ac-P2, mixed-type inhibition
Ac-KSSFR
-
N-acetyl-pentapeptide Ac-P3, mixed-type inhibition
Ac-RSRFK
-
N-acetyl-pentapeptide Ac-P1, mixed-type inhibition
Ac-RSRFS
-
N-acetyl-pentapeptide Ac-P4, mixed-type inhibition
acetone
-
increasing solvent concentration up to 80% (v/v) yields a gradual reduction in the activity of the soluble and cross-linked enzyme forms, the cross-linked enzyme aggregate shows about 40% residual activity after incubation in acetone for about 34 h
acetophenone
-
-
Acetylacetone
-
0.1 mM, 75% inhibition
acteoside
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides. Bathochromic shift of acteoside in the presence of CuSO4 (0.05 mM)
afzelechin
-
-
Agaritine
-
uncompetitive inhibition
Al3+
-
strongly inhibited diphenolase activity at ripening stage 1 and 2
albafuran A
-
-
aloesin
alpha,alpha'-dipyridyl
-
5 mM, 44% inhibition
alpha-arbutin
-
inhibition of monophenolase activity, the inhibitory activity of beta-arbutin is higher compared to alpha-arbutin, molecular docking, overview. The hydroxyl group establishes hydrogen bonds with the peroxide ion and polar contacts with a copper ion as well as with residues H259 and H263. The aromatic ring position cannot be stabilized by Pi-Pi-interactions
alpha-cyano-4-hydroxycinnamic acid
-
-
alpha-picolyl heptyl amine
-
-
alpha-picolyl nonyl amine
-
-
alpha-picolyl pentyl amine
-
-
alpha-picolyl propyl amine
-
-
alyssonoside
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides
ammonium tetramolybdate
-
anacardic acid
-
competitive inhibition
angelic acid
-
-
Anisaldehyde
Anisic acid
-
uncompetitive inhibition
anthraglycoside B
-
anthraquinone, isolated from the root of Polygonum cuspidatum
Antrodia camphorata extract
-
basidiomycete, only other effect on tyrosinase activity is prepared from Antrodia camphorata using 75% ethanol extraction
-
apigenin
-
tyrosinase inhibitors from Marrubium velutinum, flavones/flavonols
apigenin 4'-O-beta-D-glucopyranoside
-
from Guioa villosa leaf extract
apigenin-7-O-(3'',6''-di-p-coumaroyl)-glucoside
-
tyrosinase inhibitors from Marrubium velutinum, flavone/flavonol acylated glucosides
apigenin-7-O-(6''-p-coumaroyl)-glucoside
-
tyrosinase inhibitors from Marrubium cylleneum, flavone/flavonol acylated glucosides
arbutin
arbutine
-
clinically used tyrosinase inhibitor
arjungenin
-
pentacyclic triterpene extracted from Rhododendron collettianum
arjunilic acid
-
pentacyclic triterpene extracted from Rhododendron collettianum, most potent inhibitor, have potential to be used for the treatment of hyperpigmentation associated with the high production of melanocytes
artocarpanone
-
isolated from the wood of Artocarpus heterophyllus, strong mushroom tyrosinase inhibitory activity
artocarpesin
-
isolated from the wood of Artocarpus heterophyllus, strong mushroom tyrosinase inhibitory activity
artocarpetin
-
isolated from the wood of Artocarpus heterophyllus
artocarpin
-
isolated from the wood of Artocarpus heterophyllus
ascorbate
complete inhibition at 0.1 mM
ascorbic acid
azelaic acid
azide
baicalein
-
5,6,7-trihydroxyflavone, high inhibitory effects on tyrosinase. Acts as a cofactor to monophenolase
Barbituric acid
-
5.95% inhibition at 0.2 mM
Bathocuproine
-
-
Bathocuproine sulfonate
-
-
bayogenin
-
pentacyclic triterpene extracted from Rhododendron collettianum
benzaldehyde
benzhydroxamic acid
-
-
benzohydroxamic acid
-
is known to inhibit tyrosinase by chelating with copper. Completely independent of pH
benzoic acid
benzylacetone
-
a reversible, potent inhibitor of tyrosinase, mixed-type inhibitor
benzyldithiocarbamate sodium salt
-
C6H5-CH2-NH-CSS-Na, noncompetitive inhibition for both, catecholase and cresolase activities
benzylideneacetone
-
a reversible, potent inhibitor of tyrosinase, mixed-type inhibitor
benzylidenebenzofuran-3(2H)-one
-
-
beta-(N-3-hydroxypyridone-4)-alpha-aminopropionic acid
beta-arbutin
beta-mercaptoethanol
beta-picolyl heptyl amine
-
uncompetitive inhibition of monophenolase and diphenolase activities
beta-picolyl nonyl amine
-
-
beta-picolyl pentyl amine
-
uncompetitive inhibition of monophenolase and diphenolase activities
beta-picolyl propyl amine
-
uncompetitive inhibition of monophenolase and diphenolase activities
betulin
-
from Guioa villosa leaf extract
betulinic acid
-
pentacyclic triterpene extracted from Rhododendron collettianum
borax
-
71% residual activity at 10 mM
Bromoacetate
-
noncompetitive inhibition in a dose-dependent manner
brosimone I
-
isolated from the wood of Artocarpus heterophyllus
broussonin C
-
competitive inhibition
bufobutanoic acid
-
-
butylxanthate sodium salt
-
sodium salt of n-alkyl xanthate compound, competitive inhibition for the cresolase activity, competitive inhibition for the catecholase activity
CaCl2
caffeic acid
campestrol
-
isolated from Trifolium balansae, NMR structure identification, IC50: 0.00890 mM
captopril
carpachromene
-
isolated from the wood of Artocarpus heterophyllus
catechin
catechol
cefazolin
cefodizime
cetyl trimethylammonium bromide
chloroform
-
the cross-linked enzyme aggregate shows about 30% residual activity after incubation in chloroform for about 3 h
chlorogenic acid
-
tyrosinase inhibitors from Marrubium velutinum, phenolic acids
choline acetate
-
27.9% residual activity at 5% (w/v)
choline dihydrophosphate
-
27.4% residual activity at 5% (w/v)
choline methylsulfonate
-
39.7% residual activity at 5% (w/v)
choline nitrate
-
54.6% residual activity at 5% (w/v)
chrysin
-
-
chrysoeriol
-
tyrosinase inhibitors from Marrubium velutinum, flavones/flavonols
chrysoeriol 4'-O-beta-D-glucopyranoside
-
from Guioa villosa leaf extract
chrysoeriol-7-O-(3'',6''-di-p-coumaroyl)-glucoside
-
tyrosinase inhibitors from Marrubium velutinum, flavone/flavonol acylated glucosides
cinnamaldehyde
Cinnamic acid
cistanoside F
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides. Comparing the activity of tetrasaccharides with cistanoside F
citrate
-
-
citreorosein
-
anthraquinone, isolated from the root of Polygonum cuspidatum
Citric acid
crenulatoside A
-
from Guioa villosa leaf extract, inhibition at 5 mg/ml 23.7%
crenulatoside B
-
from Guioa villosa leaf extract
crenulatoside C
-
from Guioa villosa leaf extract
crenulatoside D
-
from Guioa villosa leaf extract
crotonic acid
-
-
crude ethanol phase
-
ECPE, inhibitory effect on diphenolase activity of tyrosinase
-
cudraflavone B
-
isolated from the wood of Artocarpus heterophyllus
cumic acid
-
noncompetitive inhibition
cuminaldehyde
Cupferron
Cuprizone
-
-
Cuproine
-
-
CuSO4
-
87% inhibition at 0.1 mM, 50% inhibition at 10 mM
cyanomaclurin
-
isolated from the wood of Artocarpus heterophyllus
cycloartocarpesin
-
isolated from the wood of Artocarpus heterophyllus
cycloartocarpin
-
isolated from the wood of Artocarpus heterophyllus
cyclomorusin
-
exhibits competitive inhibition characteristics. Flavone displaying tyrosinase inhibitory activity, isolated from the stem barks of Morus lhou. Inhibitory potency of this flavonoid toward monophenolase activity of mushroom tyrosinase is investigated
cysteine
D-ascorbic acid
-
met-tyrosinase is stable in anaerobic conditions but, in the presence of D-ascorbic acid undergoes an inactivation
D-ascorbic acid-6-p-hydroxybenzoic acid ester
-
irreversible inhibitor
daedalin A
-
(2R)-6-hydroxy-2-hydroxymethyl-2-methyl-2H-chromene from mycelial culture of Daedalea dickinsii
davanol
decahydro-2-naphthyl gallate
deoxyarbutin
competitive, a potent inhibitor of tyrosinase that can also act as substrate of the enzyme, shows membrane breaking and toxicity towards melanosomes, induces hydroxyl free radicals. Inhibition mechanism, overview
diethyldithiocarbamate
dihydro-4-coumaric acid
-
19.6% inhibition at 1 mM
dihydro-4-methoxycinnamic acid
-
46.4% inhibition at 1 mM
dihydrocaffeic acid
-
2.7% inhibition at 1 mM
dihydrocinnamic acid
-
40.5% inhibition at 1 mM
dihydroferulic acid
-
17.9% inhibition at 1 mM
dihydroisoferulic acid
-
60.6% inhibition at 0.33 mM
dihydromorin
-
isolated from the wood of Artocarpus heterophyllus, strong mushroom tyrosinase inhibitory activity
dihydrosinapic acid
-
22.6% inhibition at 1 mM
Dimethylsulfoxide
-
-
dioxane
-
increasing solvent concentration up to 80% (v/v) yields a gradual reduction in the activity of the soluble and cross-linked enzyme forms, the cross-linked enzyme aggregate shows about 40% residual activity after incubation in dioxane for about 62 h
dithioerythritol
-
0.05 mM, 82% inhibition of catechol oxidation, 95% inhibition of pyrogallol oxidation and 62% inhibition of dopa oxidation
dithiothreitol
-
strong inhibition
DL-dithiothreitol
DMSO
-
low concentrations of DMSO (lower than 3.5 M) lead to reversible mixed-type inhibition of the enzyme, 68.0% residual activity at 1.4 M, 52.6% residual activity at 2.1 M, 36.6% residual activity at 2.8 M, complete inhibition at 5.6 M
dopamine
-
10% inhibition at 0.1 mM
dopastin
echinacoside
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides. Bathochromic shift of echinacoside in the presence of CuSO4 (0.05 mM)
ellagic acid
emodin
-
anthraquinone, isolated from the root of Polygonum cuspidatum
epiafzelechin
-
-
epicatechin
-
-
epicatechin-(4beta-8, 2beta-O-7)-epicatechin-(4beta-8)-epicatechin
-
from Guioa villosa leaf extract, inhibition at 5 mg/ml 34.6%
epigallocatechin
-
-
epigallocatechin gallate
-
exhibits a greater anti-tyrosinase activity than arbutin
erythrodiol
-
pentacyclic triterpene extracted from Rhododendron collettianum
esculetin
ethanol
-
50% ethanol, 56% inhibition
ethyl (2E)-3-(5-hydroxy-4-oxo-4H-pyran-2-yl)prop-2-enoate
-
-
ethylxanthate sodium salt
-
sodium salt of n-alkyl xanthate compound, uncompetitive inhibition for the cresolase activity, mixed inhibition for the catecholase activity
farnesic acid
-
-
Fe2+
-
complete inhibition at 5 mM
ferulic acid
flavone
-
-
flemichin D
-
competitive inhibition
fleminchalcone A
-
i.e. 1-(5-hydroxy-2,2-dimethyl-3,4-dihydro-2H-chroman-8-yl)-3-(4-methoxyphenyl)-propan-1-one, competitive inhibition
fleminchalcone B
-
i.e. 1-(3,5-dihydroxy-2,2-dimethylchroman-6-yl)-3-(4-methoxyphenyl)propan-1-one, competitive inhibition
fleminchalcone C
-
i.e. 1-(5-hydroxy-8-(2-hydroxypropan-2-yl)-2,2-dimethyl-7,8-dihydro-2H-furo[2,3-h]chromen-6-yl)-3-(4-methoxyphenyl)propan-1-one, competitive inhibition
fluorodeoxyarbutin
-
forsythoside B
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides. Bathochromic shift of for sythoside B in the presence of CuSO4 (0.05 mM)
galangin
-
and its flavonoid mixture from Alpinia officinarum
gallic acid
gallocatechin
-
-
gamma-picolyl heptyl amine
-
uncompetitive inhibition of monophenolase activity and mixed-type inhibition of diphenolase activity
gamma-picolyl nonyl amine
-
-
gamma-picolyl pentyl amine
-
uncompetitive inhibition of monophenolase activity and mixed-type inhibition of diphenolase activity
gamma-picolyl propyl amine
-
uncompetitive inhibition of monophenolase activity and mixed-type inhibition of diphenolase activity
Ganoderma lucidum extract
-
basidiomycete, also known as Lingzhi in the herbal medicine community, exhibits significant inhibition of tyrosinase activity. No difference in inhibitory effects on tyrosinase activity is observed by Ganoderma lucidum extracts obtained by the three different extraction methods (75%, 50% ethanol, and distilled water extraction)
-
geranial
-
-
geranic acid
-
in lemongrass (Cymbopogon citratus)
geranic acid ethyl amide
-
-
geranic acid ethyl ester
-
-
geranic acid ethylene glycol ester
-
-
geraniol
-
-
geranyl gallate
glabrene
glabridin
glabridine
glutamic acid
-
individually grafted onto a novel CSG1.0 membrane as a ligand for enzyme purification
glutathione
glyasperin C
glycine
-
9% inhibition at 0.5 mM, 12% inhibition at 5 mM
glycolic acid
guanidine hydrochloride
Guanidine-HCl
-
treatment with guanidine-HCl at increasing concentrations (0-800 mM) results in a reduced activity for both enzyme forms, but aggregation as cross-linked enzyme aggregate improves tyrosinase stability at higher concentrations (above 314 mM)
H2O2
-
the enzyme becomes inactivated by hydrogen peroxide during catalysis
hesperidin
-
inhibitory effect on tyrosinase diphenolase, from citrus peel crude extracts
hexane
-
the cross-linked enzyme aggregate shows about 20% residual activity after incubation in hexane for about 24 h
hexanoic acid
-
mixed-type inhibition
Hexestrol
-
best inhibitors are tropolone, hinokitiol and hexestrol
hexylxanthate sodium salt
-
sodium salt of n-alkyl xanthate compound, competitive inhibition for the cresolase activity, competitive inhibition for the catecholase activity
hinokitiol
-
best inhibitors are tropolone, hinokitiol and hexestrol
histidine
-
individually grafted onto a novel CSG1.0 membrane as a ligand for enzyme purification
hydroquinone
hydroxyanisole
inhibitor peptide
Agaricus hortensis
-
2 natural occuring inhibitors: a 1200 Da peptide that inhibits tyrosinase competitively and second uncharacterized peptide
-
Inhibitor protein from human skin
-
-
-
iodobenzoic acid
-
1 mM, 78% inhibition
isoartocarpesin
-
isolated from the wood of Artocarpus heterophyllus, strong mushroom tyrosinase inhibitory activity
isoferulate
-
tyrosinase inhibitors from Marrubium cylleneum, phenolic acids
isoferulic acid
-
77.8% inhibition at 0.33 mM
isoliquiritigenin
isorhamnetin-3-O-(6''-OAc)-glucoside
-
tyrosinase inhibitors from Marrubium velutinum, flavone/flavonol acylated glucosides
isorhamnetin-3-O-glucoside
-
tyrosinase inhibitors from Marrubium velutinum, flavone/flavonol glucosides
isorhamnetin-3-O-rutinoside
-
tyrosinase inhibitors from Marrubium velutinum, flavone/flavonol glucosides
isorhamnetin-7-O-(6''-p-coumaroyl)-glucoside
-
tyrosinase inhibitors from Marrubium velutinum, flavone/flavonol acylated glucosides
isovaleric acid
-
-
kaempferol
kaempferol 3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside
-
IC50 of 0.1806 mg/ml
kaempferol 3-O-[beta-D-glucopyranosyl-(1->4)][alpha-L-rhamnopyranosyl-(1->6)]-beta-D-glucopyranoside
-
IC50 of 0.1935 mg/ml
kaempferol-3-O-(6''-p-coumaroyl)-glucoside
-
tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum, flavone/flavonol acylated glucosides
kaempferol-3-O-glucoside
-
tyrosinase inhibitors from Marrubium cylleneum, flavone/flavonol glucosides
kazinol C
-
competitive inhibition
kazinol D
-
-
kazinol F
-
competitive inhibition
kazinol S
-
competitive inhibition, i.e. 5'-(2-methylbut-3-en-2-yl)-6''-(3-methylbut-2-enyl)-5''-(2,3-epoxy-3-methylbytyl)-2',4',3'',4''-tetrahydroxy diphenylpropane
kazinol T
-
i.e. 5'-(2-methylbut-3-en-2-yl)-6''-(3-methylbut-2-enyl)-4'',5''-[(2-(1-hydroxy-1-methylethyl)]-dihydrofuranyl)-2',4',3''-trihydroxy diphenylpropane
KFEKKFEK
-
-
khonklonginol H
-
competitive inhibition
kojic acid
kolaflavonone
-
-
kuraridinol
-
prenylated flavonoid from Sophora flavescens, isolated from the EtOAc fraction, inhibitory effects on tyrosinase and melanin synthesis. Inhibitory activity 20times more potent than that of the positive control, kojic acid. Kuraridinol is a chalcone compound belonging to the prenylated flavonoids
kurarinol
kurarinone
-
from the root of Sophora flavescens, exhibits potent antibacterial activity, noncompetitive inhibitor, binds at an allosteric site
kuwanon A
-
-
kuwanon C
-
exhibits competitive inhibition characteristics. Flavone displaying tyrosinase inhibitory activity, isolated from the stem barks of Morus lhou. Inhibitory potency of this flavonoid toward monophenolase activity of mushroom tyrosinase is investigated
kuwanon E
-
competitive inhibitor
kuwanon U
-
-
L-ascorbate
-
significantly inhibits PPO activity, evaluated for effectiveness as an inhibitor of PPO activity, using catechol as the substrate
L-ascorbic acid
L-cysteine
L-cysteine chloride
-
competitive
L-mimosine
L-phenylalanine
L-Pro-L-Leu-Gly
-
-
L-tyrosine
-
uncompetitive inhibition
Lactic acid
-
3.73 mM, 50% inhibition of recombinant enzyme
ladanein
-
tyrosinase inhibitors from Marrubium velutinum, flavones/flavonols. Methoxylated flavones, like the methylethers of scutellarein, showed 10times lower inhibitory activity than kojic acid
lamiophlomiside
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides
lavandulifolioside
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides. Bathochromic shift of lavandulifolioside in the presence of CuSO4 (0.05 mM)
leucosceptoside A
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides. Bathochromic shift of leucosceptoside A in the presence of CuSO4 (0.05 mM)
Li+
-
72.5% residual activity at 1 mM
lupeol
-
from Guioa villosa leaf extract
lupinifolin
-
competitive inhibition
luteolin
luteolin 4'-O-beta-D-glucopyranoside
-
from Guioa villosa leaf extract, inhibition at 5 mg/ml 14%
luteolin 7-O-glucoside
luteolin-7-O-glucoside
-
tyrosinase inhibitors from Marrubium cylleneum, flavone/flavonol glucosides
macroporus adsorption resin
-
FGRE, inhibitory effect on diphenolase activity of tyrosinase
-
martynoside
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides
maslinic acid
-
pentacyclic triterpene extracted from Rhododendron collettianum
mauritianin
-
from Guioa villosa leaf extract
Metabisulfite
Methacrylic acid
-
-
methanol
Methimazole
methyl (Z)-2-((E)-2-(((E)-(5-bromothiophen-2-yl)methylene)hydrazono)-4-oxothiazolidin-5-ylidene)acetate
-
-
methyl (Z)-2-((E)-2-(((E)-4-(dimethylamino)benzylidene)hydrazono)-4-oxothiazolidin-5-ylidene)acetate
-
-
methyl arjunolate
-
pentacyclic triterpene extracted from Rhododendron collettianum
methyl gallate
-
shows a concentration-dependent inhibitory activity against tyrosinase with IC50 of 0.0625 mg/ml
MgCl2
-
10% inhibition at 0.1-1.0 mM, 11% inhibition at 10 mM
mimosine
-
inhibits monophenolhydroxylase and diphenoloxidase activity, inhibits the activity at concentrations in the microM-range, competitive inhibition
monobenzyl hydroquinone
moracin M
-
competitive inhibitor
moracin N
-
competitive inhibitor
moracinoside M
-
competitive inhibitor
morin
mormin
-
exhibits competitive inhibition characteristics. Characterized as a new flavone possesing a 3-hydroxymethyl-2-butenyl at C-3. Flavone displaying tyrosinase inhibitory activity, isolated from the stem barks of Morus lhou. Inhibitory potency of this flavonoid toward monophenolase activity of mushroom tyrosinase is investigated
morusin
-
Flavone displaying tyrosinase inhibitory activity, isolated from the stem barks of Morus lhou. Inhibitory potency of this flavonoid toward monophenolase activity of mushroom tyrosinase is investigated
morusinol
-
-
N',N'''-benzene-1,4-diylbis(1-hydroxyurea)
-
-
N'-(hydrazinylcarbonyl)-4-hydroxybenzohydrazide
-
-
N'-(hydrazinylcarbonyl)naphthalene-2-carbohydrazide
-
-
N,N-unsubstituted selenourea derivatives
-
55.5% inhibition at 0.2 mM, IC50: 0.17-0.23 mM
-
N-(2,4-dihydroxybenzyl)-2,4-dihydroxybenzamide
-
IC50: 0.029 mM
N-(2,4-dihydroxybenzyl)-3,4,5-trihydroxybenzamide
-
IC50: 0.017 mM
N-(2,4-dihydroxybenzyl)-3,4-dihydroxybenzamide
-
IC50: 0.011 mM
N-(2,4-dihydroxybenzyl)-3,5-dihydroxybenzamide
-
IC50: 0.0022 mM
N-(4-coumaroyl)serotonin
-
isolated from safflower, Carthamus tinctorius L.
N-acetyl-L-cysteine
N-benzyl-2,4-dihydroxybenzamide
-
IC50: 1.660 mM
N-benzyl-3,4,5-trihydroxybenzamide
-
IC50: 0.780 mM
N-benzyl-3,4-dihydroxybenzamide
-
IC50: 2.0 mM
N-benzyl-3,5-dihydroxybenzamide
-
IC50: 0.700 mM
N-benzylamide
-
IC50: 1.990 mM
N-benzylbenzamide derivatives
-
inhibitory potency, structure–activity relationships, overview
-
N-caffeoylserotonin
N-dihydrocaffeoyltyramine
-
complete inhibition at 0.1 mM
N-feruloylserotonin
-
isolated from safflower, Carthamus tinctorius L.
N-hydroxy-N-(phenylcarbamoyl)acetamide
-
-
N-phenylthiourea
-
PTU induces a strong inhibition of the tyrosinase activity
N-phenylurea
-
-
N-protocatechuoylserotonin
N-[2-(1H-indol-3-yl)ethyl]benzamide
-
0% inhibition at 0.1 mM; 1% inhibition at 0.1 mM
N-[2-(3,4-dihydroxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)propanamide
-
42% inhibition at 0.1 mM
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide
-
18% inhibition at 0.1 mM; 23% inhibition at 0.1 mM
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
22% inhibition at 0.1 mM; 23% inhibition at 0.1 mM
Na2S2O4
-
0.1 mM, 30% inhibition
NaF
-
inhibits moderately
NaHSO3
-
strong inhibitor
neocyclomorusin
-
competitive inhibitor
nikotiflorin
-
tyrosinase inhibitors from Marrubium velutinum, flavone/flavonol glucosides
nobiletin
-
inhibitory effect on tyrosinase diphenolase, from citrus peel crude extracts
norartocarpetin
NP-40
-
leads to a decrease in the PPO activity, whether p-cresol or catechol is used as the substrate. 50% inhibition is observed in the presence of 68 microM NP-40
o-Nitrophenol
-
competitive to catechol
o-phenanthroline hydrate
-
3 mM, 30% inhibition
O2
-
at concentrations above 30%
octanoic acid
-
mixed-type inhibition
octyl (2E)-3-(5-hydroxy-4-oxo-4H-pyran-2-yl)prop-2-enoate
-
-
oxalic acid
oxyresveratrol
p-aminobenzenesulfonamide
-
competitive inhibition
p-Aminobenzoic acid
-
individually grafted onto a novel CSG1.0 membrane as a ligand. This study indicates the p-aminobenzoic acid (ABA) grafted chitosan membrane (CSG-ABA) exhibits the best sorption capacity on tyrosinase
p-coumaric acid
p-Cresol
p-hydroxybenzoic acid
p-hydroxybenzyl alcohol
p-phenanthroline
-
5 M, complete inhibition
paeonol
-
effects of paeonol on cell growth of B16F10 melanoma cells are shown. The effect of a high dose of paeonol (200 microM) is better than that of 2 microM hydroquinone (HQ), which acts as a positive agent. Paeonol down-regulates tyrosinase expression at mRNA and protein level. And paeonol inhibits MITF mRNA expression in B16F10 melanoma cells und the phosphorylation of CREB
pentagalloyl glucopyranose
-
exhibits potent, dose-dependent inhibitory effect on tyrosinase with respect to L-DOPA with IC50 of 0.04265 mg/ml
petroleum ether
-
PCPE, inhibitory effect on diphenolase activity of tyrosinase
-
phaselic acid
-
tyrosinase inhibitors from Marrubium velutinum, phenolic acids
phenylacetic acid
-
-
phenylethylamide
-
-
phenylhydrazine
-
1 mM, 86% inhibition, noncompetitive inhibition
Phenylthiourea
phloretin
phloridzin
phloridzin dihydrate
-
-
phloroglucinol
-
enzyme-inhibitor interaction measurement by SPR
physcion
-
anthraquinone, isolated from the root of Polygonum cuspidatum. Most potent tyrosinase inhibition among the four anthraquinones examined, which is comparable to kojic acid
phytic acid
-
-
pinosylvin
-
inhibition of 32%
Poly(9)-oxyethylenelauryl ether
-
-
-
Polyvinylpyrrolidone
-
1.1%, 50% inhibition
polyvinylpyrrolidone (PVP)-wrapped fullerene derivative
-
inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene, named Radical Sponge. As compared with two major effective cosmetic additives, arbutin and L-ascorbic acid, the polyvinylpyrrolidone (PVP)-wrapped fullerene derivative (Radical Sponge) shows the more marked depigmenting effect in human melanocytes or melanoma cells
-
potassium metabisulfite
-
0.092 mM, 50% inhibition
potassium sorbate
procyanidin
-
-
procyanidin B1
-
-
prodelphindin
-
-
propelargonidin
-
-
propylxanthate sodium salt
-
sodium salt of n-alkyl xanthate compound, uncompetitive inhibition for the cresolase activity, mixed inhibition for the catecholase activity
protocatechuic acid
-
inhibition of 34%
pyrogallol
-
enzyme-inhibitor interaction measurement by SPR
quercetin
quercetin 3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside
-
IC50 of 0.1297 mg/ml
quercetin 3-O-[beta-D-glucopyranosyl-(1->4)][alpha-L-rhamnopyranosyl-(1->6)]-beta-D-glucopyranoside
-
IC50 of 0.1462 mg/ml
quercetin-3-O-(6''-p-coumaroyl)-glucoside
-
tyrosinase inhibitors from Marrubium cylleneum, flavone/flavonol acylated glucosides
quinol
-
-
Quinoline
-
-
quinone isomerase
-
RADSRADC
reduced glutathione
-
42% residual activity at 1 mM
resorcine
-
competitive to catechol
resorcinol
-
acts as enzyme substrate and inhibitor
resveratrol
-
can also act as enzyme substrate
rutin
saffron
-
enzyme-inhibitor interaction measurement by SPR
-
Salicylaldoxime
-
0.43 mM, 50% inhibition
Salicylhydroxamic acid
salicylic acid
-
uncompetitive
salicylic hydroxamic acid
-
-
serotonin
-
-
Sinapic acid
-
1.6% inhibition at 1 mM
Sodium azide
Sodium bisulfite
-
0.062 mM, 50% inhibition
sodium chloride
sodium cholate
-
in the presence of sodium cholate a decrease in PPO activity is observed when p-cresol is used as the substrate. The inhibition increases with increasing detergent concentration, until a plateau is reached. PPO activity is reduced to 50% of the control
Sodium cyanide
-
noncompetitive
sodium deoxycholate
-
in the presence of sodium deoxycholate, a decrease in PPO activity is observed when p-cresol is used as the substrate. The inhibition increases with increasing detergent concentration, until a plateau is reached. PPO activity is reduced to 50% of the control
Sodium diethyl dithiocarbamate
Sodium diethyldithiocarbamate
sodium dodecylsulfate
Sodium fluoride
sodium hydrogen sulfite
complete inhhibition at 50 mM
sodium iso-butylxanthate
-
-
sodium iso-pentylxanthate
-
-
sodium iso-propylxanthate
-
-
Sodium metabisulfite
Sodium sulfate
-
-
sodium sulfite
sodium sulphate
-
most effective inhibitor, noncompetitive inhibition
sodium thiosulfate
complete inhhibition at 50 mM
sophoraflavanone G
-
from the root of Sophora flavescens, exhibits potent antibacterial activity, noncompetitive inhibitor
soyacerebroside I
-
from Guioa villosa leaf extract, inhibition at 5 mg/ml 86.3%
stachydrine
-
tyrosinase inhibitors from Marrubium cylleneum, lignan glucosides
stachysoside D
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides
steppogenin
stigmast-5-ene-3beta,26-diol
-
isolated from Trifolium balansae, NMR structure identification, IC50: 0.00239 mM
stigmast-5-ene-3beta-ol
-
isolated from Trifolium balansae, NMR structure identification, IC50: 0.00525 mM
Streptomyces hiroshimensis strain TI-C3 with anti-tyrosinase activity
-
bacterial strain TI-C3, isolated and verified to display 498 U/ml of anti-tyrosinase acitivity. The anti-tyrosinase activity of the strain TI-C3 is improved to 905 U/ml under cultivation, usong glucose and malt extract as the sole carbon and nitrogen sources
-
succinic acid
syringic acid
-
uncompetitive inhibition
Tannic acid
-
enzyme-inhibitor interaction measurement by SPR
terrein
tert-butanol
-
the cross-linked enzyme aggregate shows about 50% residual activity after incubation in tert-butanol for about 326 h
tetrabutylammonium acetate
-
24.1% residual activity at 5% (w/v)
tetrabutylammonium methylsulfonate
-
45.3% residual activity at 5% (w/v)
tetramethylammonium acetate
-
30% residual activity at 5% (w/v)
Thai honey
-
different types of Thai honey on pathogenic bacteria causing skin diseases, tyrosinase enzyme and generating free radicals, antibacterial and antioxidant activities of Thai honey, overview. Honey from longan flower gives the highest activity on multiresistent Staphylococcus aureus (MRSA isolate 49) when compared to the other types of honey, with a minimum inhibitory concentration of 12.5% v/v and minimum bactericidal concentration of 25% v/v. The antioxidant activity of the honey obtained from coffee pollen is the highest with highest level of phenolic and flavonoid compounds. Honey from coffee flower shows inhibition of tyrosinase by 63.46%. The highest activity of tyrosinase inhibition from manuka honey is also very high
-
Thiobarbituric acid
-
8.21% inhibition at 0.2 mM
thiodeoxyarbutin
-
Thiosemicarbazide
-
-
Thiourea
tianmushanol
-
-
tiglic acid
-
-
tiliroside
-
tyrosinase inhibitors from Marrubium velutinum, flavone/flavonol acylated glucosides
trans-cinnamaldehyde
-
competitive inhibition
trans-geranic acid
-
-
trans-N-caffeoyltyramine
-
complete inhibition at 0.1 mM
trans-N-dihydro-p-hydroxycinnamoyltyramine
-
complete inhibition at 0.1 mM
tributylammonium dihydrophosphate
-
27.5% residual activity at 5% (w/v)
triethylammonium dihydrophosphate
-
23.4% residual activity at 5% (w/v)
trifolirhizin
-
prenylated flavonoid from Sophora flavescens, isolated from the EtOAc fraction, inhibitory effects on tyrosinase and melanin synthesis
trimethylammonium dihydrophosphate
-
12% residual activity at 5% (w/v)
trimethylammonium methylsulfonate
-
40.9% residual activity at 5% (w/v)
Triton X-100
tropolone
Tween 20
Tween 80
-
leads to a decrease in the PPO activity, whether p-cresol or catechol is used as the substrate. 60% inhibition is observed in the presence of 32-60 microM Tween 80
tyramine
-
23% inhibition at 0.1 mM
tyrosol
-
the compound is a substrate and an inhibitor for tyrosinase, 18% inhibition at 1.5 mM
umbelliferone
-
-
Vanillin
-
-
velutinoside I
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides
velutinoside II
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides. Bathochromic shift of velutinoside II in the presence of CuSO4 (0.05 mM)
velutinoside III
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides
velutinoside IV
-
tyrosinase inhibitors from Marrubium velutinum, phenylethanoid glycosides
YRSRKYSSWY
[1,1''-biphenyl]-3-carboxylic acid
-
little availability of the carboxylic acid group in 2-phenylbenzooic acid to chelate with cupric ions in the active site
[1,1'-biphenyl]-2-carboxylic acid
-
-
[1,1'-biphenyl]-4-carboxylic acid
-
-
[2-(furan-2-ylmethylene-hydrazono)-4-oxo-thiazolidin-5-ylidene]-acetic acid methyl ester
-
-
[2-[(4-benzyloxy-benzylidene)-hydrazono]-4-oxo-thiazolidin-5-ylidene]-acetic acid methyl ester
-
-
[4-oxo-2-(pyridin-4-ylmethylene-hydrazono)-thiazolidin-5-ylidene]-acetic acid methyl ester
-
non-competitive inhibition
additional information
-